The PI3K/Akt/mTOR pathway was found to play an important role in the progression of HCC in processes like proliferation, metastasis, chemotherapy and radiotherapy resistance, and energy metabolism (Liu et al., 2016). Here, AKT1 is linked to hepatocellular carcinoma.